<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>Quantum Media Group, LLC News Releases</title>
		<link>https://feeds.newsfilecorp.com/company/10011</link>
		<description>Latest news from Quantum Media Group, LLC, as distributed by TMX Newsfile.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Tue, 10 Mar 2026 17:05:58 -0400</lastBuildDate>
		<image>
			<url>https://www.newsfilecorp.com/images/newswire/customer-logos/10011.jpg</url>
			<title>Quantum Media Group, LLC News Releases</title>
			<link>https://feeds.newsfilecorp.com/company/10011</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/company/10011"/>
		<item xml:lang="en">
			<title>Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives</title>
			<link>https://www.newsfilecorp.com/release/222150/Sleep-Apnea-Pill-Quantum-Research-Survey-Shows-Sleep-Apnea-Patients-Seeking-CPAP-Alternatives</link>
			<description>A new survey conducted by Quantum Research Group, LLC finds that more than half of patients diagnosed with sleep apnea are not satisfied with their current treatment. Nearly 70 percent of patients express a willingness to switch to a prescribed pill-form treatment. New York, New York--(Newsfile Corp. - September 9, 2024) - Quantum Research Group, LLC just published the results of a new survey entitled "Understanding Obstructive Sleep Apnea Treatment Experiences and Patient Perspectives."...&lt;img src="https://api.newsfilecorp.com/newsinfo/222150/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 09 Sep 2024 08:00:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/222150</guid>
			<atom:subtitle>A new survey conducted by Quantum Research Group, LLC finds that more than half of patients diagnosed with sleep apnea are not satisfied with their current treatment. Nearly 70 percent of patients express a willingness to switch to a prescribed pill-form treatment.</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Quantum Research Group Survey Reports Investor Insights About Psychedelic Stocks</title>
			<link>https://www.newsfilecorp.com/release/218432/Quantum-Research-Group-Survey-Reports-Investor-Insights-About-Psychedelic-Stocks</link>
			<description>A new survey conducted by Quantum Research Group, LLC finds that 66 percent of psychedelic-friendly investors plan to boost their investments in the sector over the next 12 months New York, New York--(Newsfile Corp. - August 5, 2024) - Quantum Research Group, LLC published the results of a new survey entitled "Investor Insights into Psychedelic Stocks." According to the data gathered in April 2024, 66 percent of investors are psychedelic friendly, but only 6 percent are invested in one or more...&lt;img src="https://api.newsfilecorp.com/newsinfo/218432/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Mon, 05 Aug 2024 07:30:00 -0400</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/218432</guid>
			<atom:subtitle>A new survey conducted by Quantum Research Group, LLC finds that 66 percent of psychedelic-friendly investors plan to boost their investments in the sector over the next 12 months</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Ari Zoldan to Moderate The Deal Flow Microcap Conference in Atlantic City, NJ Jan 30th-Feb 1st 2024</title>
			<link>https://www.newsfilecorp.com/release/193793/Ari-Zoldan-to-Moderate-The-Deal-Flow-Microcap-Conference-in-Atlantic-City-NJ-Jan-30thFeb-1st-2024</link>
			<description>The three-day conference is the largest independent event for microcap companies. It's expected to draw over 700 people including investors and presenting companies. New York, New York--(Newsfile Corp. - January 10, 2024) - Quantum Media Group CEO Ari Zoldan will moderate The Microcap Conference in Atlantic City Jan. 30 - Feb.1, 2024. The three-day conference will feature presentations from publicly traded microcap companies and qualified private companies in healthcare, technology, financial...&lt;img src="https://api.newsfilecorp.com/newsinfo/193793/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;</description>
			<pubDate>Wed, 10 Jan 2024 13:08:00 -0500</pubDate>
			<category domain="https://www.newsfilecorp.com/language">en</category>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/193793</guid>
			<atom:subtitle>The three-day conference is the largest independent event for microcap companies. It's expected to draw over 700 people including investors and presenting companies.</atom:subtitle>
		</item>
	</channel>
</rss>
